1. NHS Executive.Clinical Guidelines: using clinical guidelines to improve patient care within the NHS. London: HMSO;1996.

2. Editorial Team TCP a CG. Specialised Register: Search strategies for identification of studies. The Cochrane Library. Oxford: Update Soft- ware. Updated Quarterly.

3. Scottish Intercollegiate Guidelines Network. Breast cancer in women:a national clinical guideline. Edinburgh: SIGN;1998.SIGN Publication Nº29.

4. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Critically appraising the evidence: is this evidence about a diagnostic test valid? Evidence based Medicine: How to practice and each EBM. Edinburgh: Churchill Livingstone; 1997:81-4.

5. Bernstein SJ, Hofer TP, Meijler AP, Rigter H. Setting standards for  effectiveness : a comparison of expert panel sand decision analysis. Int J Qual Health Care1997;9:255-63.

6. Macfarlane A, Mugford M. Care of mothers and babies. Birth counts: Statistics of pregnancy and Childbirth. London: The Stationery Office, 2000:191-242.

7. Calder AA, Embrey MP,Hillier K.Extra-amniotic prostaglandin E2 for the induction of labour at term. J Obstet Gynaecol Br Cwlth 1974;81:39- 46.

8. American College of Obstetrician sand Gyneco- logists. Induction of labour. Washington DC: ACOG;1999.Practice Bulletin 10.

9. Society of Obstetricians and Gynaecologists of Canada. Induction of Labour. Ottawa: SOGC; 1996.SOGC Policy Statement 57.

10. Rev. Hosp. Mat. Inf. Ramón Sardá 2002, 21 (2) 10. Royal College of Obstetricians and Gynaecologists. The use of electronic fetal monitoring: The use and interpretation of cardiotocography in intrapart umfetal surveillance.London: RCOG Press;2001.Evidence-based Clinical Guideline 8.

11. Garcia J, Redshaw, Fitzsimmons B,Keene J.First Class Delivery: The National survey of womens view maternity care. Abingdon: Audit Commission Publications;1998.

12. Sawai SK, O.Brien WF.Outpatient cervical ripening.Clin Obstet Gynecol 1995; 38: 301-9.

13. Hodnett ED.Care giver support for women during child birth. Cochrane Database Syst Rev 2000;1:1-9.

14. Departmentof Health.Changing child birth. Report of the Expert Maternity Group (Chairman: BaronessCumberlege).London:HMSO;1993.

15. Audit Commission for Local Authorities and the NHS in England and Wales. First Class Delivery: Improving Maternity Services in England and Wales. Abingdon: Audit Commission Publications;1997.

16. Kulier R, Hofmeyr GJ. Tocolytics for suspected intrapartum fetal distress. Cochrane
Database Syst Rev 2001;2.

17. Dobson PC, Abell DA, Beischer NA. Mortality and morbidity of fetal growth retardation. Aust NZJ Obstet Gynaecol 1981;21:69-72.

18. Lelaidier C, Baton C, Benifla JL, Fernandez H, Bourget P, Frydman R. Mifepristone for labour induction after previous caesarean section.BrJ Obstet Gynaecol 1994;101:501-3.

19. MoralesW, Lazar AJ. Expectant management of rupture of membranes at term. South Med J 1986;79:955-8.

20.Sellers SM, Ah Moye M, MacKenzie IZ.Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. Proceedings of 1st European Congress on Prostaglandins in Reproduction, Vienna, Austria 1988:128.

21. Wing DA, Lovett K, Paul RH. Disruption of prior uterine incision following misoprostol for labor induction inwomenwith previous cesarean delivery. Am J Obstet Gynecol 1998;91:828-30.

22. Vause S, Macintosh M. Evidence based case report: Use of prostaglandins to induce labour in women with a caesarean section scar. BMJ 1999;318:1056-8.

23. Hickok DE, Gordon DC, Milberg JA,Williams MA, Daling JR. The frequency of breech presentation by gestational age at birth: a large population based study. Am J Obstet Gynecol 1992;166:851-2.

24. Hannah ME,Hannah WJ,Hewson SA, Hodnett ED,Saigal S, Willan AR. Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Lancet 2000;356:1375-83.

25. Maternal and Child Health Research Consortium. Confidential Enquiry into Stillbirths and Deaths in Infancy: Fifth Annual Report,1 January 31 December 1996 . London: Maternaland Child Health Research Consortium;1998.

26. Orhue AAE. A randomised trial of 45 minutes and 15 minutes incremental oxytocin in fusion regimes for the induction of labour in women of high parity. Br J Obstet Gynaecol 1993;100:126-9.

27. Hilder L,Costeloe K,ThilaganathanB.Prolonged pregnancy: evaluating gestation-specific risks offetalandinfantmortality.BrJObstetGynaecol 1998;105:169-173.

28. CotziasCS,Paterson-BrownS,FiskNM.Prospective risk of unexplained stillbirth in singleton pregnanciesat term: populationbasedanalysis. BMJ1999;319:287-8.

29. Hilder L, Costeloe K, Thilaganathan B. Prospec- tive risk of stillbirth. Study.s results are flawed by relianceoncumulativeprospective risk.BMJ 2000;320:444.

30. Yudkin P, Redman C. Prospective risk of still- birth. Impending fetal death must be identified andpre-empted.BMJ2000;320:444.

31. Boulvain M, Faltin D, Ibecheole V, Irion O. Pro- spective risk of stillbirth. Randomised trials of earlierinductionoflabourareneeded.BMJ2000; 320:444.

32. elQarmalawiAM,MorsyAH,alFadlyA,ObeidA, HashemM.Labetalolvs.methyldopainthetreatmentof pregnancy-induced hypertension. IntJ GynaecolObstet1995;49:125-30.

33. Crowley P. Interventions for preventing or im- proving the outcome of delivery at or beyond term.CochraneDatabaseSystRev2001;2.

34. Neilson JP. Ultrasound for fetal assessment in early pregnancy. Cochrane Database Syst Rev 2001;2.

35. GoereeR,HannahM,HewsonS.Cost-effectiveness ofinductionoflabourversusserialantenatalmoni toringintheCanadianMulticentrePosttermPreg- nancyTrial.CMAJ1995;152:1445-50.

36. Gafni A,GoereeR,MyhrTL,HannahME,Black- house G, Willan AR, et al. Induction of labour versusexpectantmanagementforprelabourrupture of the membranes at term: an economicevaluation.CMAJ1997;157:1519-25.

37. Hawthorne G, Irgens LM, Lie RT. Outcome of pregnancy in diabeticwomenin northeast EnglandandinNorway,1994-7.BMJ2000;321:730-1.

38. Casson IF, Clarke CA,HowardCV, McKendrick Guías de manejo. Inducción al trabajo de parto o Valenti o 87 o O,PennycookS,PharoahPO,et al.Outcomesof pregnancyininsulindependentdiabeticwomen: results of a five year population cohort study.
BMJ1997;315:275-8.

39. HawthorneG,RobsonS,RyallEA,SenD,Roberts SH,WardPlattMP.Prospectivepopulationbased survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Preg-
nancyAudit,1994.BMJ1997;315:279-81.

40. HunterDJS.Diabetesinpregnancy.InChalmers I, Enkin MW, Keirse MJNC, editors. Effective Care in Pregnancy and Childbirth:578-93. Ox- ford: Oxford University Press; 1989.

41. AckerDB,GregoryKD,SachsBP,FriedmanEA. Risk factors for Erb-Duchenne palsy. Obstet Gynecol1988;71:389-92.

42. Scottish Intercollegiate Guidelines Network. Management of diabetes in pregnancy: A National Clinical Guideline recommended for use inScotlandbytheScottishIntercollegiateGuide-
linesNetwork.Scotland:SIGN;1996.

43. BoulvainM,Stan C, Irion O. Elective delivery in diabetic pregnant women. Cochrane Database SystRev2001;2.

44. Kjos SL, Henry OA, Montoro M, Buchanan TA, MestmanJH.Insulin-requiringdiabetesinpregnancy: a randomized trial of active induction of laborandexpectant management.AmJ Obstet Gynecol1993;169:611-15.

45. Minakami H and Sato I. Reestimating date of delivery in multifetal pregnancies [published erratumappearsinJAMA1996;276:452].JAMA, 1996;275:1432-4.

46. SuzukiS,OtsuboY,SawaR,YoneyamaY, Araki T. Clinical trial of induction of labor versus expectant management in twin pregnancy. GynecolObstetInvest2000;49:24-27.

47. TanBP,HannahME.Prostaglandinsversusoxy- tocin for prelabour rupture ofmembranesat or nearterm.CochraneDatabaseSystRev2001;2.

48. Hannah ME,HuhC, Hewson SA, Hannah WJ. Postterm pregnancy: putting the merits of a policy of induction of labor into perspective. Birth1996;23:13-19.

49. SinghalKK,LaGammaEF.Managementof168 neonates weighing more than 2000 g receiving intrapartum chemoprophylaxis for chorioamnionitis. Evaluation ofanearly discharge strategy.ArchPediatrAdolescMed1996;150:158-63.

50. Major CA, de VecianaM,Lewis DF,MorganMA. Preterm premature rupture ofmembranesandabruptio placentae: is there an association between these pregnancy complications? Am J ObstetGynecol1995;172:672-6.

51. RibDM,ShererDM,WoodsJR,Jr.Maternaland neonatal outcome associated with prolonged premature rupture of membranes below 26 gestation.AmJPerinatol1993;10:369-73.

52. Mercer BM, Crocker LG, Pierce WF, Sibai BM. Clinical characteristics and outcome of twin gestation complicated by preterm premature reofthemembranes.AmJObstetGynecol
1993;168:1467-73.

53. KleinJM.Neonatal morbidityandmortality secondary to premature rupture of membranes. ObstetGynecolClinNorthAm1992;19:265-80.

54. Kurki T, Hallman M, Zilliacus R, Teramo K,Ylikorkala O. Premature rupture of the membranes: effect of penicillin prophylaxisandlong- term outcome of the children. Am J Perinatol 1992;9:11-16.

55. Mercer BM, Moretti ML, Prevost RR, Sibai BM Erythromycintherapyinpretermprematurerup ture of the membranes: a prospective, randomized trial of 220 patients.AmJ Obstet Gynecol 1992;166:794-802.

56. Seo K, McGregor JA, French JI. Preterm birth is associated with increased risk of maternal and neonatalinfection.ObstetGynecol1992;79:75-80.

57. James D. Preterm prelabour rupture of membranes.ArchDisChild1991;66;812-5.

58. LevineCD.Prematureruptureofthemembranes andsepsis in preterm neonates.NursRes1991;40:36-41.

59. Lubchenco LO, Searls DT, Brazie JV. Neonatal mortality rate: relationship to birth weight and gestationalage.JPediatr1972;81:814-22.

60. Savitz DA, Ananth CV, Luther ER, Thorp JM. Influence of gestational age on the time from spontaneous rupture of the chorioamniotic membranesto the onset of labor.AmJPerinatol 1997;14:129-33.

61. TanBP,HannahME.Prostaglandinsversusoxytocin for prelabour rupture of membranes at term.CochraneDatabaseSystRev2001;2.

62. TanBP,HannahME.Prostaglandinsforprelabour ruptureofmembranesatornearterm.Cochrane DatabaseSystRev2001;2.

63. Tan BP, Hannah ME. Oxytocin for prelabour ruptureofmembranesatornearterm.Cochrane
DatabaseSystRev2001;2.

64. JohnstoneFD.Prediction ofmacrosomiain diabetic pregnancy.ContempRevObstet Gynaecol
1997;9:113-20.

65. Irion O, Boulvain M. Induction of labour for suspectedfetalmacrosomia.CochraneDatabase
SystRev2001;2.

66. OutJJ,VierhoutME,VerhageF,Duivenvoorden HJ,WallenburgHC.Characteristicsandmotives
ofwomenchoosing elective induction of labour.
o 88 o Rev. Hosp. Mat. Inf. Ramón Sardá 2002, 21 (2) JPsychosomRes1986;30:375-80.

67. Erkkola R, Nikkanen V. Precipitate labour.Ann ChirGynaecol1978;67:150-3.

68. Boulvain M., Stan C, Irion O.Membranesweeping for induction of labour. Cochrane Database SystRev2001;2.

69. MelzackR.Theshort-formMcGillpainquestionnaire.Pain1987;30:191-7.

70. TanBP,Kelly AJ. Intravenous oxytocin alone for induction of labour. Cochrane Database Syst Rev2001;3.

71. BothaDJ,HowarthGR.Oxytocinandamniotomy for induction of labour.CochraneDatabaseSyst Rev2001;2.

72. Davies LM. Drummond MF. Management of labour:consumerchoiceandcost implications.
JObstetGynaecol1991;11:23-33.

73. BoulvainM,KellyAJ,StanC, IrionO.Intracervical prostaglandins for induction of labour.
CochraneDatabaseSystRev2001;3.

74. KellyAJ,KavanaghJ,ThomásJ.Vaginalprostaglandin(PGE2andPGF2)forinductionoflabourat term.CochraneDatabaseSystRev2001;2.

75. MacKenzieIZ,BurnsE.Randomisedtrial ofone versus two doses of prostaglandinE2for induction of labour: 1. Clinical outcome. Br J Obstet Gynaecol1997;104:1062-7.

76. MacKenzie IZ, Magill P, Burns E. Randomised trial of one versus two doses of prostaglandinE 2 for induction of labour: 2. Analysis of cost. Br JObstetGynaecol1997;104:1068-72.

77. NettenA,KnightJ,DennettJ,CooleyR, Slight A. Ready reckoner forstaff costs in the NHS. Canterbury:PSSRU,University of Kent;1998.

78. Ross EL and et al. High dose vs. standard dose oxytocin in parturients with uterine risk factors:
a randomised double blind trial. Am J Obstet Gynecol1998;178:595

79. HourvitzA, AlcalayM,KorachJ,LuskyA,Barkai G, Seidman DS. A prospective study of highversus low-dose oxytocin for induction of labor. ActaObstetGynecolScand1996;75:636-641

80. GoniS,SawhneyH,GopalanS. Oxytocin induction of labor: a comparison of 20- and 60-mindose increment levels. Int J Gynaecol Obstet 1995;48:31-36.

81. Crane J, Reardon E.Aprospective randomized study of high dose vs. low dose oxytocin infusion for labour induction. Proceedings of 49th annual clinical meeting of the Society of ObstetriciansandGynaecologists ofCanada,Ottawa, Ontario,1993;109.

82. Lazor LZ, PhilipsonEH,Ingardia CJ, Kobetitsch ES, Curry SL.Arandomized comparison of 15-and 40- minute dosing protocols for labor augmentationandinduction. ObstetGynecol1993;
82:1009-12.

83. SatinAJ,HankinsGD,YeomansER.Aprospective study of two dosing regimens of oxytocin for the induction of labor in patients with unfavorable cervices.AmJObstetGynecol1991;165:980-4.

84. Orhue AAE. Incremental increases in oxytocin infusion regimens for induction of labor at termin primigravidas:Arandomized controlled trial. ObstetGynecol1994;83:229-33

85. OrhueAAE.Arandomizedtrial of30-minand15 min oxytocin infusion regimen for induction of labor at term in women of low parity. Int J GynaecolObstet1993;40:219-25

86. MercerB,PilgrimP,SibaiB.Laborinductionwith continuous low-dose oxytocin infusion: a randomizedtrial.ObstetGynecol1991;77:659-63.

87. ChuaS,ArulkumaranS,KurupA,Anandakumar C,TayD,RatnamSS.Doesprostaglandin confer significant advantage over oxytocin infusion for nulliparaswithprelaborruptureofmembranes atterm?ObstetGynecol1991;77:664-7.

88. Royal College of Obstetricians and Gynaecologists. Induction of London:RCOGPress;
1998.Guideline16.

89. BoulvainM,KellyAJ,StanC,IrionO.Mechanical methodsforinductionoflabour.CochraneDatabaseSystRev2001;3.

90. HuttonEand Mozurkewich E. Extra-amniotic prostaglandin for induction of labour.Cochrane DatabaseSystRev2001;2.

91. Luckas M, Bricker L. Intravenous prostaglandinsfor induction of ur.CochraneDatabase
SystRev2001;2.

92. French L. Oral prostaglandin for induction of  bour.CochraneDatabaseSystRev2001;2.

93. Neilson JP. Mifepristone for induction of labour. CochraneDatabaseSystRev2001;2.

94. ThomásJ,KellyAJ,KavanaghJ.Oestrogenswith or without amniotomy for induction of labour.CochraneDatabaseSystRev2001;3.

95. KellyAJ,KavanaghJ,ThomásJ. Corticosteroids for induction of CochraneDatabaseSyst
Rev2001;2.

Comentarios